Online inquiry

IVTScrip™ mRNA-Human ANAPC16, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17870MR)

This product GTTS-WK17870MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANAPC16 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001242546.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 119504
UniProt ID Q96DE5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANAPC16, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17870MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK10514MR IVTScrip™ mRNA-Human AAK1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AAK1
GTTS-WK12291MR IVTScrip™ mRNA-Human AGBL2, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AGBL2
GTTS-WK18310MR IVTScrip™ mRNA-Human AGPAT4, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AGPAT4
GTTS-WK13175MR IVTScrip™ mRNA-Human AEBP1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AEBP1
GTTS-WK17798MR IVTScrip™ mRNA-Human ALDH2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ALDH2
GTTS-WK14324MR IVTScrip™ mRNA-Human ADCY9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADCY9
GTTS-WK8834MR IVTScrip™ mRNA-Human ACOT2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACOT2
GTTS-WK15904MR IVTScrip™ mRNA-Human AGMO, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AGMO
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW